Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US1638511089
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG005H82GB2
CC
Chemours Co
GICS: Materials · SECTOR: EQTY · SUB-SECTOR: Chemicals - Specialty
NAME
Chemours Co
ISIN
US1638511089
TICKER
CC
MIC
XNYS
REUTERS
CC.N
BLOOMBERG
CC US
Tue, 03.11.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - November 3, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.11.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.11.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - November 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.11.2026       Chemours
US1638511089

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws.If you invested in Chemours, you...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 31.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 31.10.2026       Chemours
US1638511089

NEW ORLEANS, Oct. 30, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company ("Chemours" or the "Company") (NYSE: CC), if they purchased or otherwise acquired The Chemours...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 29, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.10.2026       Chemours
US1638511089

LOS ANGELES, Oct. 29, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated t...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Chemours
US1638511089

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 29.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 29, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Chemours
US1638511089

Important Information Regarding Section 20(a) Individual Liability Claims: The lawsuit names Chemours CEO Denise Dignam and CFO Shane Hostetter as control persons over statements that allegedly overstated Opteon aftermarket demand. It also alleges that the two executives sold more than $485,000 of company stock during the Class Period.NEW YORK, Oc...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Chemours
US1638511089

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 26-cv-01299, is on behalf of a class con...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Chemours
US1638511089

Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products.New York, New York--(Newsfile Corp. - October 29, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Ch...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.10.2026       Chemours
US1638511089

Chemours shares shed $3.34 in a single session after a cut to 2026 earnings guidance. The lawsuit alleges that management overstated Opteon aftermarket demand while an oversupplied refrigerant channel weighed on sales.NEW YORK, Oct. 28, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in The Chemours Company (NYSE: CC) of a pending...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 27, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 27.10.2026       Chemours
US1638511089

Did you buy CC securities between February 20, 2026 and August 4, 2026?Affected CC Investor SummaryWho: The Chemours Company (NYSE: CC)What: Securities fraud class action lawsuit filedClass Period: February 20, 2026 through August 4, 2026Deadline to Seek Lead Plaintiff Status: December 7, 2026Key Lawsuit Allegations: Material misstatements and/or...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 27.10.2026       Chemours
US1638511089

WILMINGTON, Del., Oct. 27, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2026. The dividend will be paid on December 15, 2026, to stockholders of record as of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 27.10.2026       Chemours
US1638511089

Did you buy CC securities between February 20, 2026 and August 4, 2026?Affected CC Investor SummaryWho: The Chemours Company (NYSE: CC)What: Securities fraud class action lawsuit filedClass Period: February 20, 2026 through August 4, 2026Deadline to Seek Lead Plaintiff Status: December 7, 2026Key Lawsuit Allegations: Material misstatements and/or...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 27.10.2026       Chemours
US1638511089

Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products.NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (N...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.10.2026       Chemours
US1638511089

Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours Company (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours offers a range of industrial and specialty chemical products fo...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.10.2026       Chemours
US1638511089

Lead Plaintiff Deadline December 7, 2026NEW YORK, Oct. 26, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a nationally recognized securities litigation law firm announces that a securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 26, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 26.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 24.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 24.10.2026       Chemours
US1638511089

Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products.New York, New York--(Newsfile Corp. - October 24, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Ch...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 24.10.2026       Chemours
US1638511089

NEW YORK and NEW ORLEANS , Oct. 23, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Sat, 24.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 23, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Fri, 23.10.2026       Chemours
US1638511089

The Chemours Company ("Chemours" or the "Company") (NYSE: CC) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 7, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 20, 2026 through August 4, 2026,...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 22.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 22, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 22.10.2026       Chemours
US1638511089

NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 26-cv-01299, is on behalf of a class con...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 22.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in The Chemours to Contact Him Directly to Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 22, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors of the December 7, 2026 dead...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Thu, 22.10.2026       Chemours
US1638511089

Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products.New York, New York--(Newsfile Corp. - October 22, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Ch...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Chemours
US1638511089

WILMINGTON, Del., Oct. 21, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its third quarter 2026 financial results after market on Monday, November 2, 2026.The Company expects to hold its conference call to discuss its third quarter 2026 financial results at 8:00...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Chemours
US1638511089

San Diego, California--(Newsfile Corp. - October 21, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours Company (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the "Class Period"). Chemours of...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Chemours
US1638511089

Complaint alleges The Chemours Company misled investors between February 20, 2026 and August 4, 2026; investors may seek lead plaintiff role by December 7, 2026LOS ANGELES, Oct. 21, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP ("Glancy") announced today that the class action lawsuit covers investors who bought The Chemours Company ("...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Chemours
US1638511089

Promise vs. Reality: The Chemours Performance Gap. Management cited "very stable volume" in May, but the lawsuit alleges an oversold Opteon aftermarket channel was already eroding 2026 demand.NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP highlights the alleged Chemours promise-reality gap at the center of a securities fraud cla...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 21, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Chemours
US1638511089

The Chemours Company (NYSE: CC) shareholders should email fletcher@fmoorelaw.comNEW YORK, Oct. 20, 2026 /PRNewswire/ -- What is the Investigation About?On August 4, 2026, after the market closed, Chemours announced second-quarter results and reduced its full-year adjusted EBITDA guid...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Chemours
US1638511089

Suit alleges The Chemours Company failed to disclose key facts to investors from February 20, 2026 through August 4, 2026; lead plaintiff deadline is December 7, 2026BENSALEM TOWNSHIP, Pa., Oct. 20, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith today reported that a securities class action lawsuit is pending against The Chemours Company...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Chemours
US1638511089

Lead Plaintiff Deadline December 7, 2026NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a nationally recognized securities litigation law firm announces that a securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Chemours
US1638511089

Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products.NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (N...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Chemours
US1638511089

Lawsuit alleges The Chemours Company made misleading statements to investors from February 20, 2026 to August 4, 2026; lead plaintiff motions are due December 7, 2026LOS ANGELES, Oct. 19, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz today announced a class action lawsuit against The Chemours Company ("Chemours" or the "Company") (NYSE: CC...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.10.2026       Chemours
US1638511089

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Chemours
US1638511089

LOS ANGELES, Oct. 19, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated t...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 19, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Chemours Company (NYSE: CC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations of th...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Chemours
US1638511089

New York, New York--(Newsfile Corp. - October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Chemours
US1638511089

Action reflects Chemours' commitment to innovation, intellectual property protection, our customers, and fair competition in the refrigerants industryWILMINGTON, Del., Oct. 19, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company, today announces that it has taken action to protect its intellectual property...
Read more
Chemours
Technical Analysis Termsheets Terminal
Permalink